Faculty Opinions recommendation of Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials.

Author(s):  
Xavier Leleu
Sign in / Sign up

Export Citation Format

Share Document